Retour
28
Fourchette du Jour
183,28 €
187,59 €
Fourchette 52 Semaines
168,14 €
310,50 €
Volume
1 566 951
Moyenne 50J / 200J
196,45 €
/
254,18 €
Clôture Précédente
184,07 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 33,5 | 0,4 |
| P/B | 4,2 | 2,9 |
| ROE % | 13,9 | 3,7 |
| Net Margin % | 28,4 | 3,8 |
| Rev Growth 5Y % | 14,6 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 14,63% annually over 5 years — strong growth
Earnings grew 27,27% over the past year
ROE of 13,93% — decent returns on equity
Net margin of 28,44% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 1,39B in free cash flow
Croissance
Revenue Growth (5Y)
14,63%
Revenue (1Y)16,34%
Earnings (1Y)27,27%
FCF Growth (3Y)25,14%
Qualité
Return on Equity
13,93%
ROIC9,40%
Net Margin28,44%
Op. Margin28,68%
Sécurité
Debt / Equity
0,01
Current Ratio4,89
Interest Coverage0,00
Valorisation
P/E Ratio
33,50
P/B Ratio4,22
EV/EBITDA31,78
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,34% | Revenue Growth (3Y) | 16,27% |
| Earnings Growth (1Y) | 27,27% | Earnings Growth (3Y) | 31,49% |
| Revenue Growth (5Y) | 14,63% | Earnings Growth (5Y) | 20,76% |
| Profitability | |||
| Revenue (TTM) | 3,20B | Net Income (TTM) | 908,91M |
| ROE | 13,93% | ROA | 10,12% |
| Gross Margin | 75,53% | Operating Margin | 28,68% |
| Net Margin | 28,44% | Free Cash Flow (TTM) | 1,39B |
| ROIC | 9,40% | FCF Growth (3Y) | 25,14% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 4,89 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 33,50 | P/B Ratio | 4,22 |
| P/S Ratio | 9,53 | PEG Ratio | 1,42 |
| EV/EBITDA | 31,78 | Dividend Yield | 0,00% |
| Market Cap | 30,45B | Enterprise Value | 29,12B |
Income Statement
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3,20B | 2,75B | 2,36B | 2,16B | 1,85B |
| Net Income | 908,91M | 714,14M | 525,71M | 487,71M | 427,39M |
| EPS (Diluted) | 5,44 | 4,32 | 3,22 | 3,00 | 2,63 |
| Gross Profit | 2,41B | 2,05B | 1,69B | 1,55B | 1,35B |
| Operating Income | 916,37M | 691,44M | 429,33M | 459,09M | 505,50M |
Balance Sheet
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 8,98B | 7,34B | 5,91B | 4,80B | 3,82B |
| Total Liabilities | 1,76B | 1,51B | 1,27B | 1,09B | 904,83M |
| Shareholders' Equity | 7,21B | 5,83B | 4,64B | 3,72B | 2,91B |
| Total Debt | 95,86M | 75,78M | 55,78M | 60,98M | 54,59M |
| Cash & Equivalents | 1,42B | 1,12B | 703,49M | 886,47M | 1,14B |
| Current Assets | 8,00B | 6,31B | 5,00B | 3,97B | 3,11B |
| Current Liabilities | 1,64B | 1,40B | 1,18B | 1,01B | 840,78M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#849 of 1024
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026